Ionis Pharmaceuticals
IONS
IONS
379 hedge funds and large institutions have $6.8B invested in Ionis Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 122 increasing their positions, 113 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
379
Holders Change
+14
Holders Change %
+3.84%
% of All Funds
6.72%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
67
Increased
122
Reduced
113
Closed
49
Calls
$88.4M
Puts
$35M
Net Calls
+$53.3M
Net Calls Change
+$57.4M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$135M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$107M |
| 3 |
BlackRock
New York
|
+$72.7M |
| 4 |
JPMorgan Chase & Co
New York
|
+$64.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$46M |
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$271M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$76M |
| 3 |
Two Sigma Investments
New York
|
-$44.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$41.2M |
| 5 |
Renaissance Technologies
New York
|
-$40.8M |
